Clinical Trial Update: Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 trial comparing two dosing schedules of Telintra in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Telintra

Snippet

Sponsor: Telik | Conditions: Myelodysplastic Syndrome (MDS) | Phase 2 | Status: COMPLETED